Thus, we studied the distribution and the evolution of anti-DSG3 IgG subclasses in patients with PV using an addressable laser bead immuno assay (ALBIA) and correlated the distribution of anti-DSG3 IgG subclasses with the clinical course of patients included in the Ritux 3 trial. This evidence concerns the gene DSG3 and acquired polycythemia vera.